BE768925A - Derives d'adenosine et procede de preparation - Google Patents

Derives d'adenosine et procede de preparation

Info

Publication number
BE768925A
BE768925A BE768925A BE768925A BE768925A BE 768925 A BE768925 A BE 768925A BE 768925 A BE768925 A BE 768925A BE 768925 A BE768925 A BE 768925A BE 768925 A BE768925 A BE 768925A
Authority
BE
Belgium
Prior art keywords
preparation
adenosine derivatives
adenosine
derivatives
Prior art date
Application number
BE768925A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BE768925A publication Critical patent/BE768925A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
BE768925A 1970-06-30 1971-06-23 Derives d'adenosine et procede de preparation BE768925A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5750770 1970-06-30

Publications (1)

Publication Number Publication Date
BE768925A true BE768925A (fr) 1971-11-03

Family

ID=13057634

Family Applications (1)

Application Number Title Priority Date Filing Date
BE768925A BE768925A (fr) 1970-06-30 1971-06-23 Derives d'adenosine et procede de preparation

Country Status (8)

Country Link
US (1) US3796700A (fr)
BE (1) BE768925A (fr)
CA (1) CA954856A (fr)
DE (1) DE2131938A1 (fr)
FR (1) FR2100839B1 (fr)
GB (1) GB1351501A (fr)
HU (1) HU163640B (fr)
NL (1) NL7108858A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426337B1 (en) 1996-12-24 2002-07-30 Smithkline Beecham Corporation 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US6762170B1 (en) 1998-01-31 2004-07-13 Smithklinebeecham Corporation 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US7737126B2 (en) 2004-05-24 2010-06-15 Glaxo Group Limited Purine derivative
US7985740B2 (en) 2005-07-19 2011-07-26 Glaxo Group Limited Purine derivatives as agonists of the adenosine A2A receptor

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922261A (en) * 1972-06-21 1975-11-25 Merck Patent Gmbh Adenosine derivative
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5066655A (en) * 1987-04-24 1991-11-19 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
US5155098A (en) * 1989-06-09 1992-10-13 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
DK0550631T3 (da) * 1990-09-25 1997-01-20 Rhone Poulenc Rorer Int Forbindelser med blodtrykssænkende virkning og virkning mod iskæmi
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
DK62592D0 (fr) * 1992-05-14 1992-05-14 Novo Nordisk As
US6495528B1 (en) 1998-06-23 2002-12-17 Smithkline Beecham Corporation 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives
US7205404B1 (en) 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
JP4979866B2 (ja) 1999-09-08 2012-07-18 リガンド・ファーマシューティカルズ・インコーポレイテッド 肝臓に特異的なドラッグデリバリーのためのプロドラッグ
JP2017512183A (ja) 2014-02-13 2017-05-18 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
US11970482B2 (en) 2018-01-09 2024-04-30 Ligand Pharmaceuticals Inc. Acetal compounds and therapeutic uses thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426337B1 (en) 1996-12-24 2002-07-30 Smithkline Beecham Corporation 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US6528494B2 (en) 1996-12-24 2003-03-04 Brian Cox 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US6762170B1 (en) 1998-01-31 2004-07-13 Smithklinebeecham Corporation 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US7737126B2 (en) 2004-05-24 2010-06-15 Glaxo Group Limited Purine derivative
US7985740B2 (en) 2005-07-19 2011-07-26 Glaxo Group Limited Purine derivatives as agonists of the adenosine A2A receptor

Also Published As

Publication number Publication date
DE2131938A1 (de) 1972-01-05
GB1351501A (en) 1974-05-01
CA954856A (en) 1974-09-17
US3796700A (en) 1974-03-12
FR2100839A1 (fr) 1972-03-24
FR2100839B1 (fr) 1974-09-06
NL7108858A (fr) 1972-01-03
HU163640B (fr) 1973-09-27

Similar Documents

Publication Publication Date Title
BE776510A (fr) Procede de preparation en continu d'alcoxysilanes et d'alcoxy-polysiloxanes
BE768925A (fr) Derives d'adenosine et procede de preparation
BE788958A (fr) Derives d'adenosine et leur procede de preparation
BE806146A (fr) Derives de triazolinone et procede de preparation
BE768722A (fr) Derives d'acide oxazolyl-acetique et oxazolyl-coumarines
BE777223A (fr) Derives d'adenosine et leur fabrication
BE768754A (fr) Procede perfectionne de preparation d'explosifs en suspension epaissis
BE766242A (fr) Derives de la 4(3h-)-quinazolinone et leur
BE758380A (fr) Procede de preparation de derives d'aryl-cetones
BE768697A (fr) Derives d'acide quinoleinecarboxylique et leur procede de preparation
BE745104A (fr) Derives de la pteridine et mode de preparation
BE771115A (fr) Derives de la quinoleine et leur preparation
BE788509A (fr) Derives de dihydroquinoleine et procede de preparation
BE761927A (fr) Procede de preparation de derives de 5-imino-1,2,4-triazine et produitsobtenus
BE771009R (fr) Derives de la
BE763425A (fr) Procede de preparation de nouveaux derives de s-triazine et de leurs sels
CH548369A (fr) Procede de preparation d'acides fluorene-2-acetiques et de leurs derives.
BE754823A (fr) Derives de l'amonioadamantane et leur procede de preparation
BE781474A (fr) Procede de preparation de derives bisubstitues en n' de la n-o-cyanophenyl-formamidine et de leurs sels
BE766521A (fr) Nouveaux derives de la cyclopentanone et procede de preparation
BE763307R (fr) Alpha-cetoglutarate de pyridoxime et de derives de
BE775867A (fr) Derives d'imidazoline et leur procede de preparation
BE821084R (fr) Derives de triazolinone et procede de preparation
BE776965A (fr) Nouveaux derives de la malonyluree et procede de preparation
BE763712A (fr) Procede de preparation de 2.6-dialkyl-3-amino-6(beta-cyanethyl)-cyclohexene-(2)-ones et de leurs derives